AGP Executive Report
Last update: 10 hours agoCancer Care in Europe: The EU Commission has approved pembrolizumab (Keytruda) plus enfortumab vedotin (Padcev) as a perioperative treatment for adults with resectable muscle-invasive bladder cancer who can’t have cisplatin, with the option to continue after surgery—also covering Iceland. Health Funding Link: North Macedonia has been added to the EU4Health programme, letting health authorities access funding from 1 January 2026 to boost prevention, cancer and cardiovascular care, mental health, and medicines planning. Wellness Science: A new look at sauna research highlights strong associations with lower cardiovascular death risk in long-running studies, with benefits appearing dose-dependent. Local Health Costs (Europe): Netherlands health spending rose 6.1% in 2025, with long-term care the fastest-growing part. Pregnancy Protections (Sports): A CAS ruling backs a footballer’s pregnancy-related confidentiality and compensation rights after a club ended her contract. Public Health Watch: A report flags rising antimicrobial resistance risks, including pharmaceutical contamination in water. Iceland Angle: Iceland is named in multiple EU health and healthcare access updates, including EU4Health and cancer approvals.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.